Dobutamine Stress Echocardiography Identifies Anthracycline Cardiotoxicity | Zendy

Yves Cottin | Zendy; Isabelle L’Huillier | Zendy; Olivier Casasnovas | Zendy; C. Geoffroy | Zendy; Denis Caillot | Zendy; Marianne Zeller | Zendy; Éric Solary | Zendy; H. Guy | Zendy; JeanEric Wolf | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dobutamine Stress Echocardiography Identifies Anthracycline Cardiotoxicity

Author(s) -

Yves Cottin,

Isabelle L’Huillier,

Olivier Casasnovas,

C. Geoffroy,

Denis Caillot,

Marianne Zeller,

Éric Solary,

H. Guy,

JeanEric Wolf

Publication year - 2000

Publication title -

european journal of echocardiography

Language(s) - Uncategorized

Resource type - Journals

eISSN - 1525-2167

pISSN - 1532-2114

DOI - 10.1053/euje.2000.0037

Subject(s) - medicine , dobutamine , anthracycline , cardiotoxicity , ejection fraction , chemotherapy , subclinical infection , cardiology , diastole , stress echocardiography , hemodynamics , heart failure , cancer , blood pressure , coronary artery disease , breast cancer

Anthracyclines are effective anti-cancer agents, but their therapeutic value is limited by their myocardial toxicity. We assessed the physiological responses of stress echocardiography at low doses of dobutamine (DSE) in patients treated with anthracycline.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research